Lymphangitic carcinomas of the lung as presentation of prostatic cancer. A case report.
Lymphangitic carcinomatosis of the lung is a late and often fatal manifestation of cancer. We describe a case of a biopsy-proved pulmonary lymphangitic carcinomatosis in an asymptomatic 61-year-old man. The pulmonary picture proved to be the initial sign of a prostatic cancer. Therapy with LH-RH analogues and antiandrogens achieved a complete clearance of lung involvement.
Miseria
S
S
Department of Clinical Oncology, University of Ancona, Italy.
Torresi
U
U
Menichetti
E T
ET
Tummarello
D
D
Baldelli
S
S
Murer
B
B
Cellerino
R
R
D002064:Buserelin / Q000031:analogs & derivatives / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy / Q000473:pathology* / Q000556:secondary; D005485:Flutamide / Q000627:therapeutic use; D017273:Goserelin; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*; D008205:Lymphangitis / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology*
D017273:Goserelin; D005485:Flutamide; D002064:Buserelin